Within the NAFLD pathway, upregulated genes like MAPK12, COX6A2, and RXRA may facilitate the production of lipid-derived volatile flavor compounds by boosting fatty acid oxidation, lipid metabolism, and thermogenesis. Here, RXRA is linked to metabolic dysfunction-associated steatotic liver disease.